Patent details

EP1641793 Title: NOVEL IMIDAZOPYRIDINE COMPOUND II WITH THERAPEUTIC EFFECT

Basic Information

Publication number:
EP1641793
PCT Application Number:
PCT/SE/2004/001013
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047490511
PCT Publication Number:
WO/2004/113339
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL IMIDAZOPYRIDINE COMPOUND II WITH THERAPEUTIC EFFECT
French Title of Invention:
NOUVEAU COMPOSE IMIDAZOPYRIDINE II PRESENTANT UN EFFET THERAPEUTIQUE
German Title of Invention:
NEUE IMIDAZOPYRIDINVERBINDUNG II MIT THERAPEUTISCHER WIRKUNG
SPC Number:

Dates

Filing date:
23/06/2004
Grant date:
13/02/2008
EP Publication Date:
13/02/2008
PCT Publication Date:
29/12/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/04/2006
EP B1 Publication Date:
13/02/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/06/2010
Expiration date:
23/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/06/2004
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
18/04/2008
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

Name:
NORDBERG Peter
Address:
Sweden (SE)

Priority

Priority Number:
0301904
Priority Date:
26/06/2003
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
C07D 471/04;
Filing date Document type Number of pages